Asia-Pacific Lipidomics Equipment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Targeted and Untargeted), Offerings {MS-Based Lipidomics Techniques [Mass Spectrometers Equipped with Ion Sources (Turbo-) ESI/Nano-ESI/APCI, Auto

Asia-Pacific Lipidomics Equipment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Targeted and Untargeted), Offerings {MS-Based Lipidomics Techniques [Mass Spectrometers Equipped with Ion Sources (Turbo-) ESI/Nano-ESI/APCI, Autosamplers, Micropumps, UV Detectors, UPLC, Variable-Length Fluorescence Detectors, and Others], Assays For Lipid Metabolism, Lipid Flux Using Heavy Isotope-Labeled Precursors, Software & Services, and Others}, Services [Biomarker Identification, Bioinformatic Analysis & Data Interpretation, Molecular Analysis of a Broad Spectrum of Phospholipids (Lipid Fingerprinting), Analysis & Identification of Unusual Lipids, Semiquantitative & Quantitative Analysis, Lipid Flux Studies, and Others], and End User (Molecular Research, Cellular Research, Clinical Research, Tissue & Organ Research, Data Research, Organism Research, Technical Services & Prototyping, Production, and Others)

The APAC lipidomics equipment market is expected to grow from US$ 261.28 million in 2022 to US$ 614.01 million by 2028. It is estimated to register a CAGR of 15.3% from 2022 to 2028.

Escalating Investments by Governments and Market Players is Driving the APAC Lipidomics Equipment Market

The biopharmaceutical industry invests enormously in research and development. Together, China and India generate a huge demand for lipidomics equipment due to the large number of projects underway in several end-user industries in these countries. Further, key market players are establishing new R&D and innovation centers in Asian countries and collaborating with local players to capitalize on opportunities provided by these countries. For instance, The China MS Center was established in the Beijing branch of Shimadzu (China) Co., Ltd. in October 2015 as a research and development facility to increase the market share of mass spectrometers and promote joint research and joint development projects in the local area. Further, government and private universities are undertaking several initiatives to spread awareness about lipidomics and its applications. For example, in 2018, the Department of Science and Technology (DST-FIST) of the Government of India and Amity University established Amity Lipidomics Research Facility (ALRF). In August 2022, Amity University conducted a week-long hands-on training on materials characterization, lipidomics, and proteomics technique, which was sponsored by the DST under its Synergistic Training program Utilizing the Scientific and Technological Infrastructure (STUTI). Moreover, Central Food Technological Research Institute (CSIR) also opened a lipidomic center. The center was successfully established in 2016, and it gives access to a wide range of instruments required for high-end lipid research. Therefore, the growing investment is driving the APAC lipidomics equipment market .

APAC Lipidomics Equipment Market Overview

The APAC lipidomics equipment market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of APAC. China dominated the market in 2022. The lipidomics equipment market in China is expected to grow during the forecast period owing to the factors such as growing chronic diseases, including cancer, in China and rising technological advancements in lipidomics equipment. As per Globocan 2020 report, lung cancer is the most common cancer in China, and 815,563 (17.9%) cases were registered in 2020. This is likely to increase the demand for various therapeutics and medicines in China. Further, 555,477 (12.2%) new cases of colorectal cancer, 478,508 (10.5%) cases of stomach cancer, 410,038 (9%) cases of liver cancer, 416,371 (9.1%) cases of breast cancer, and 1,892,797 (41.4%) cases of other cancers were found in China in 2020. The increasing prevalence of cancer in China is contributing to the growth of the lipidomics equipment market, owing to the application of equipment in research and diagnosis procedures. China has seen a rapid increase in investment in the healthcare industry, especially in the country's approach to precision medicine. Precision medicine is being adopted and put into practice rapidly on a large scale in China. The country's healthcare system has seen a significant transformation since the China Precision Medicine Initiative launched in 2016—a 15-year program with US$ 9,200 million in funding—which intends to enhance the nation's reputation in precision medicine. The increasing demand for precision medicine is expected to provide an opportunity for APAC lipidomics equipment market.

APAC Lipidomics Equipment Market Revenue and Forecast to 2028 (US$ Million)

APAC Lipidomics Equipment Market Segmentation

The APAC lipidomics equipment market is segmented based on type, offerings, services, end user, and country.

Based on type, the APAC lipidomics equipment market is bifurcated into targeted and untargeted. The targeted segment held a larger market share in 2022.

Based on offerings, the APAC lipidomics equipment market is segmented into MS-based lipidomics techniques, assays for lipid metabolism, lipid flux using heavy isotope-labeled precursors, software & services, and others. The MS-based lipidomics techniques segment held the largest market share in 2022. The MS-based lipidomics techniques segment is further categorized into mass spectrometers equipped with ion sources (turbo-) ESI/nano-ESI/APCI, autosamplers, micropumps, UV detectors, UPLC, variable-length fluorescence detectors, and others.

Based on services, the APAC lipidomics equipment market has been segmented into biomarker identification, bioinformatic analysis & data interpretation, molecular analysis of a broad spectrum of phospholipids (lipid fingerprinting), analysis & identification of unusual lipids, semiquantitative & quantitative analysis, lipid flux studies, and others. The biomarker identification segment held the largest market share in 2022.

Based on end user, the APAC lipidomics equipment market is segmented into molecular research, cellular research, clinical research, tissue & organ research, data research, organism research, technical services & prototyping, production, and others. The molecular research segment held the largest market share in 2022.

Based on country, the APAC lipidomics equipment market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of APAC. Our regional analysis states that China dominated the market in 2022.

Agilent Technologies, Inc.; Bruker; Cayman Chemical; Creative Proteomics; IonBench; PerkinElmer Inc.; Sciex; Shimadzu Corporation.; and Thermo Fisher Scientific Inc. are among the leading companies operating in the APAC lipidomics equipment market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC lipidomics equipment market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the APAC lipidomics equipment market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the lipidomics equipment market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution